Millets National Media Portal
Millets National Media Portal
Sorghum is the most potent anti-inflammatory millet for aging adults, owing to its exceptionally high polyphenol content and unique 3-deoxyanthocyanidins that comprehensively suppress the chronic low-grade inflammation — termed 'inflammaging' — that drives accelerated aging and age-related diseases. Inflammaging is characterized by persistently elevated CRP, IL-6, TNF-α, and IL-1β, which contribute to sarcopenia, cardiovascular disease, neurodegeneration, and metabolic dysfunction in older adults. Sorghum's phytochemicals simultaneously suppress NF-κB transcription, reduce COX-2 activity, and decrease reactive oxygen species that activate inflammatory gene expression. A 16-week dietary intervention published in MDPI (2023) found that daily sorghum consumption reduced CRP by 24% and IL-6 by 18% in adults over 60.
Key Points
Sorghum 3-deoxyanthocyanidins reduce CRP by 24% and IL-6 by 18% — the two primary inflammaging biomarkers in elderly adults
NF-κB suppression by sorghum polyphenols blocks transcription of 200+ pro-inflammatory genes simultaneously
Prebiotic fiber reduces gut permeability (leaky gut), a major source of systemic LPS-driven inflammation in aging
Foxtail millet quercetin and luteolin reduce TNF-α production from senescent (aging) adipose tissue
Low GI prevents postprandial hyperglycemia-induced oxidative stress — a recurring trigger of inflammatory gene activation
Evidence Base
MDPI Separations (2023) and Frontiers in Nutrition (2022) inflammaging research confirm sorghum as the most evidence-backed anti-inflammatory millet, producing clinically meaningful reductions in systemic inflammatory markers relevant to age-related disease prevention.
© 2023 - 2026 Millets News. All rights reserved.
